Provided by Tiger Trade Technology Pte. Ltd.

AtriCure

55.14
+1.552.89%
Post-market: 55.150.0100+0.02%19:30 EDT
Volume:1.62M
Turnover:87.56M
Market Cap:2.79B
PE:261.53
High:55.25
Open:52.51
Low:52.00
Close:53.59
52wk High:61.70
52wk Low:25.36
Shares:50.63M
Float Shares:48.59M
Volume Ratio:1.20
T/O Rate:3.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2108
EPS(LYR):-0.2400
ROE:2.15%
ROA:1.25%
PB:5.41
PE(LYR):-229.75

Loading ...

Analysts Offer Insights on Healthcare Companies: Shattuck Labs (STTK) and Atricure (ATRC)

TIPRANKS
·
Oct 02

AtriCure CTO Salvatore Privitera Disposes of $271,140 in Common Shares

Reuters
·
Sep 25

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Atricure (ATRC) and Stryker (SYK)

TIPRANKS
·
Sep 17

AtriCure, Inc. : Stifel Raises Target Price to $65 from $50

THOMSON REUTERS
·
Sep 17

U.S. Research Roundup-Celcuity, Fluence Energy, Salesforce

Reuters
·
Sep 17

AtriCure CTO Salvatore Privitera Sells 3,657 Shares for $201,135

Reuters
·
Sep 10

S&P 500 to Add Bloom Energy, Illumina and Everpure in September Rebalance

Tiger Newspress
·
Sep 05

AtriCure CTO Salvatore Privitera Sells 7,763 Shares Worth $407,558

Reuters
·
Sep 04

Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating

MT Newswires Live
·
Sep 02

AtriCure is Maintained at Buy by Needham

Dow Jones
·
Sep 02

AtriCure, Inc. : Needham Raises Target Price to $64 from $45

THOMSON REUTERS
·
Sep 02

AtriCure is Maintained at Overweight by Piper Sandler

Dow Jones
·
Aug 28

U.S. Research Roundup-CrowdStrike, Nvidia, Macerich

Reuters
·
Aug 27

AtriCure Chief Legal Officer Karl S. Dahlquist Sells 9,370 Shares for $458,069.30

Reuters
·
Aug 26

AtriCure to Join Wells Fargo Health Care Conference Fireside Chat

Reuters
·
Aug 25

AtriCure is Maintained at Buy by BTIG

Dow Jones
·
Aug 24

AtriCure (ATRC) Is Up 10.1% After Unveiling 2030 Revenue Goal And Trial-Driven Expansion Plans

Simply Wall St.
·
Aug 15

AtriCure (ATRC) Lifted Its Guidance, Is The Stock Fully Priced?

Simply Wall St.
·
Aug 10

AtriCure Director Maggie Yuen Sells 3,500 Shares Worth $134,470

Reuters
·
Aug 07

AtriCure Chief Scientific Officer Vinayak Doraiswamy Disposes of $233,280 in Common Shares

Reuters
·
Jul 31